跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELREXFIO 40 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ELREXFIO 40 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
ELREXFIO 40 MG/ML SOLUCION INYECTABLE
Pfizer Europe Ma Eeig
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 18, 2023
Approval ID
818733f0789a8469
Company
Pfizer Europe Ma Eeig
Type
Standard
Approval Details
Approval Id
818733f0789a8469
Drug Cima Aemps Name
ELREXFIO 40 MG/ML SOLUCION INYECTABLE
Register Number
1231770001
Holder Company Name
Pfizer Europe Ma Eeig
Marketing Company Name
Pfizer S.L.
Holder Company Detail Path
/organization/pfizer-europe-ma-eeig
Authorization Date
2023-12-18
Dosage Form
SOLUCIÓN INYECTABLE
Dose
40 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Pfizer Europe Ma Eeig
Company Detail Path
/organization/pfizer-europe-ma-eeig
Company Information
Pharmaceutical Company Name
Pfizer Europe MA EEIG
Country Name
United Kingdom
Active Ingredients
ELRANATAMAB
40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 18, 2023
Approval ID
818733f0789a8469
Type
Standard
Back to CIMA-AEMPS Approvals